NIMBLE Diagnostics
PrivateLast Round
Series A
May 18, 2025
Total Funding Raised
$16.35M
Company Overview
NIMBLE Diagnostics operates in Healthcare & Life Sciences and is based in Badalona. Its latest recorded funding round was a Series A round in May 2025.
NIMBLE Diagnostics is a medical technology company developing a non-invasive diagnostic device for the detection of cardiovascular conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NIMBLE Diagnostics Comparables
Compare NIMBLE Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Edwards Lifesciences | 63% | |
| Sensible Medical Innovations | 61% | |
| Cortex, Inc. | 61% |
For institutional investors. Book with your work email.
NIMBLE Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 18, 2025 | ||||
| Grant | Nov 2, 2023 | ||||
| Grant | Apr 26, 2023 | ||||
| Seed | Jan 15, 2023 | ||||
| Grant | Apr 8, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NIMBLE Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Accelerator | Grant |
| Grow Venture Partners | Seed |
| Namarel Ventures | Seed |
| University of Barcelona | Seed |
| European Union | Grant |
| Inveniam Group | Seed |
| EIC Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 29, 2025
Developing a first-of-its-kind microwave-based medical device.
- Nov 2, 2023
Secured $2.65M from EIC Accelerator and EIC Fund.
For institutional investors. Book with your work email.
NIMBLE Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NIMBLE Diagnostics's valuation, stock price, and market status.
Is NIMBLE Diagnostics a public or private company?
NIMBLE Diagnostics is a private company.
What is the current stock price of NIMBLE Diagnostics?
NIMBLE Diagnostics is a private company, so its shares have no public market price. Caplight tracks NIMBLE Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NIMBLE Diagnostics worth (valuation)?
Valuation information for NIMBLE Diagnostics is not publicly available.
Can I buy NIMBLE Diagnostics stock?
NIMBLE Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NIMBLE Diagnostics's last funding round?
NIMBLE Diagnostics's most recent funding round was Series A on May 18, 2025.
Who are the main investors in NIMBLE Diagnostics?
Key investors in NIMBLE Diagnostics include Grow Venture Partners, Namarel Ventures.
Will NIMBLE Diagnostics IPO soon?
No public IPO plans have been announced for NIMBLE Diagnostics.
How can I track NIMBLE Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in NIMBLE Diagnostics's shares on secondary markets.